Frank Flider

Title: Frank Flider: Innovator in Safflower Biotechnology

Introduction

Frank Flider is a notable inventor based in Scottsdale, AZ (US). He has made significant contributions to the field of biotechnology, particularly in the development of safflower plants with enhanced gamma-linolenic acid (GLA) content. His work has implications for various health conditions, showcasing the intersection of agriculture and medicine.

Latest Patents

Frank Flider holds 2 patents related to his innovative work. His latest patent focuses on the preparation of gamma-linoleic acid in safflower plants, specifically from the seeds. The invention utilizes nucleic acid sequences and constructs that encode fatty acid desaturase sequences. This technology enables the generation of transgenic safflower plants that express these sequences, resulting in high levels of GLA in the seeds. The invention also includes methods for treating diseases such as nervous system disorders, inflammatory conditions, cancer, and cardiovascular disorders using oils derived from these transgenic safflower seeds.

Career Highlights

Flider is associated with Arcadia Biosciences, Inc., a company dedicated to developing innovative agricultural solutions. His work at Arcadia has positioned him as a key player in the biotechnology sector, contributing to advancements that benefit both agriculture and health.

Collaborations

Throughout his career, Frank Flider has collaborated with notable colleagues, including Vic C Knauf and Christine K Shewmaker. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Frank Flider's contributions to safflower biotechnology exemplify the potential of agricultural innovations to address health challenges. His patents and work at Arcadia Biosciences, Inc. highlight the importance of integrating science and technology for societal benefit.